Table 2 This table provides an overview of initiatives undertaken by Gulf Cooperation Council (GCC) countries to govern AI in healthcare, categorized by the relevant phase of the TLA

From: A “True Lifecycle Approach” towards governing healthcare AI with the GCC as a global governance model

Country

Initiative

Description

Phase of TLA

Qatar

Research Guidelines for Healthcare AI Development

Provides guidance on ethical considerations, data privacy, and bias mitigation in AI research. Centralized governance enables streamlined ethical reviews and standardized research protocols.

Research and Development

Saudi Arabia

Guidance on AI and ML Technologies Based Medical Devices (MDS-G010)

Establishes a comprehensive regulatory framework for AI medical devices. Centralized authority facilitates consistent enforcement and rapid updates to regulations.

AI Systems Approvals

UAE

Abu Dhabi Policy on the Use of AI in Healthcare/Dubai Policy on the Use of AI in Healthcare

Abu Dhabi: Mandates safeguards like “graceful degradation” and feedback loops. Dubai: Requires transparency, validation, and accountability mechanisms. National-level coordination allows for unified policy adaptation and efficient resource allocation.

Post-Implementation Governance

Back to article page